**Background**
Glutamate receptors are a group of ionotropic receptors that play a fundamental role in synaptic transmission and plasticity within the central nervous system. Among these, the GluR5 subunit of the AMPA/kainate receptor family is of particular interest due to its distinct pharmacological properties and its role in modulating excitatory neurotransmission. Understanding the specific activation mechanisms of GluR5 is crucial for researching neurological disorders and the molecular basis of synaptic signaling. In this context, we will introduce a selective glutamate receptor GluR5 activator – ATPA.
**Definition**
ATPA is a selective GluR5 activator with a high potency for the wild-type receptor, exhibiting an EC50 value of 0.66 μM for GluR5wt.
**In Vitro Studies**
The ATPA biological activity is characterized by its ability to activate various GluR5 variants with differing efficiencies. According to the ATPA description, the compound shows EC50 values of 9.5 μM for GluR5(S741M), 1.4 μM for GluR5(S721T), 23 μM for GluR5(S721T, S741M), 32 μM for GluR5(S741A), 18 μM for GluR5(S741L), and 14 μM for GluR5(S741V). These results indicate that the activation of the receptor is significantly controlled by the serine 741 residue. Furthermore, ATPA in vitro data demonstrates that the compound also activates GluR1 variants, although generally with lower potency. Specifically, it activates GluR1wt, GluR1(M722S), GluR1(T700S), GluR1(T700S, M722S), and GluR1(M722A) with EC50 values of 62, 4.6, 97, 14, and 97 μM, respectively. In conclusion, ATPA is a selective activator of the glutamate receptor GluR5 whose efficacy is modulated by specific amino acid residues.
Keywords
ATPA, 140158-50-5, iGluR, Ionotropic glutamate receptors, Inhibitor, inhibitor, inhibit
References